Skip to main content

The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.

Publications

644 Publications Available
Bioinformatics

Researchers introduce a sequential trimming-and-retrieving alignment approach for investigating DNA methylation patterns, which significantly improves the number of mapped reads and covered CpG sites.

N Engl J Med

Researchers performed genomewide analyses of 293 lower-grade gliomas from adults, incorporating exome sequence, DNA copy number, DNA methylation, messenger RNA expression, microRNA expression, targeted protein expression, and tested for correlation with clinical outcomes.

Nature Chemical Biology

Investigators determine the molecular mechanism of the chemotherapeutic agent didemnin B and find a biomarker to predict sensitivity.

Molecular Cell

This review offers a practical resource to compare and contrast these technologies, guiding the investigator when and where to use this fantastic array of powerful tools.

Nature Methods

Researchers report the BAMSurgeon tool for simulating cancer genomes and the results of 248 analyses of three in silico tumors.

J Am Chem Soc.

Researchers report on  the discovery of a novel, small-molecule modulator of lysosomal acidification derived from diversity-oriented synthesis through high-content screening.

Oncogene

To uncover novel mechanisms of resistance to anti-HER2 therapy in breast cancer, researchers performed a kinase open reading frame screen to identify genes that rescue HER2-amplified breast cancer cells from HER2 inhibition or suppression.

Journal of Clinical Investigation

Researchers discuss BRAF inhibitor-resistant melanomas can be actionably classified using protein expression patterns, even without identification of the underlying genetic alteration.

Clinical Cancer Research

New ways of suppressing KRAS gene expression and of harnessing the immune system to exploit previously unrecognized vulnerabilities in human cancers. 

Genome Medicine

A review about 3D culture models for cancer research.